David Aggen: Alcohol Consumption May Reduce Immunotherapy Effectiveness in Cancer Patients
David Aggen/ Memorial Sloan Kettering Cancer Center/LinkedIn

David Aggen: Alcohol Consumption May Reduce Immunotherapy Effectiveness in Cancer Patients

David Aggen, Genitourinary Medical Oncologist at Memorial Sloan Kettering Cancer Center and Assistant Professor of Medicine at Weill Cornell Medicine, shared on X:

“Patients frequently ask about drinking alcohol while receiving immunotherapy – not only can alcohol on immunotherapy lead to side effects and liver toxicity, it may actually impair efficacy of the treatment.

Title: Alcohol Use Reduces the Efficacy of Anti-PD1 Immunotherapy by Disrupting Antitumor Immunity

Authors: Kristen N. Gilley, Jason Garness, Ali Khan, Baylee R. Materia, Brandon Carpenter, Mitra Shabrang, Wolfgang Beckabir, Mark G. Woodcock, Chad V. Pecot, Benjamin G. Vincent, Leon G. Coleman, Jr.

Read The Full Article.”

You can also read:

David Aggen: Alcohol Consumption May Reduce Immunotherapy Effectiveness in Cancer Patients